Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma
{{custom_author.name}}, {{article.zuoZheEn}}
Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |